Scholars@Duke
John Preston Claiborne

John Preston Claiborne

Assistant Professor of Medicine
Medicine, Hematologic Malignancies and Cellular Therapy

Scholarly Works

Chemotherapy regimens with second generation tyrosine kinase inhibitors for BCR-ABL B-cell acute lymphoblastic leukemia: comparative outcomes and role of allogeneic hematopoietic cell transplantation.

Journal article Leuk Lymphoma · April 2026 Outcomes for adults with Philadelphia chromosome positive pre-B cell acute lymphoblastic leukemia (Ph + B-ALL) have improved dramatically, but questions remain regarding the optimal induction regimen and role of allogeneic hematopoietic cell transplantatio ... Full text Link to item Cite

Post-allogeneic hematopoietic cell transplantation outcomes are similar after hypomethylating agent/venetoclax and intensive, cytarabine-based remission induction for Acute Myeloid Leukemia when using standardized, contemporary transplant techniques

Conference Blood · November 3, 2025 AbstractIntroduction: Since the introduction of hypomethylating agent (HMA) and venetoclax combination therapy for acute myeloid leukemia ( ... Full text Cite

Efficacy and safety of blinatumomab for CD19 + acute leukemias in patients historically excluded from clinical trials due to comorbidities.

Journal article Leuk Res · October 2025 BACKGROUND: Blinatumomab has proven efficacy in the frontline, consolidation, and relapsed/refractory settings in B cell acute lymphoblastic leukemia. Its efficacy and safety among patients commonly excluded from clinical trials are unknown. PATIENTS AND M ... Full text Link to item Cite

CD19 CAR-T With Axicabtagene Ciloleucel in R/R Large B-Cell Lymphoma With/Without Prior Autologous Stem Cell Transplant.

Journal article Clin Lymphoma Myeloma Leuk · June 2025 BACKGROUND: Anti-CD19 CAR-T therapy has been a breakthrough in treatment of primary refractory or relapsed large B-cell lymphoma (r/r LBCL) and is poised to supplant previous second line of high dose chemotherapy and autologous stem cell transplantation (H ... Full text Link to item Cite

Erwinia asparaginase (crisantaspase) increases plasma levels of serine and glycine

Journal article Frontiers in Oncology · December 12, 2022 The impact of asparaginases on plasma asparagine and glutamine is well established. However, the effect of asparaginases, particularly those derived from Erwinia chrysanthemi (also called crisantaspase), on circulating le ... Full text Cite

Managing post allograft relapse of myeloid neoplasms: azacitidine and donor lymphocyte infusions as salvage therapy.

Journal article Leuk Lymphoma · November 2019 Azacitidine (Aza) may promote cytotoxic effects against hematologic tumor cells when combined with donor lymphocyte infusions (DLIs). This study sought to verify Aza-DLI's efficacy and tolerability in patients with relapsed acute myeloid leukemia (AML) or ... Full text Link to item Cite

Recent trends in diabetes-related consumer health information technology research.

Conference Annu Int Conf IEEE Eng Med Biol Soc · July 2019 Diabetes-related consumer health information technology (CHIT) has been designed to facilitate self-management practices, and its use has improved health outcomes for many consumers. This analysis sought to identify tendencies in diabetes-related CHIT rese ... Full text Link to item Cite